Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer

Journal of Pathology

Volumn 190, Issue 4, 2000, Pages 430-436

  Leek, Russell D ^a   Hunt, Nicholas C ^a   Landers, Robert J ^b   Lewis, Claire E ^b   Royds, Janice A ^b   Harris, Adrian L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Angiogenesis; Breast cancer; EGFR; Macrophage; TNF alpha; VEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GRADING; CELL COUNT; CELL INFILTRATION; CELL SURVIVAL; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MACROPHAGES; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034021278     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6     Document Type: Article

References (36)

1. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
2. Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 1994; 56: 423-435.
3. Dachs GU, Stratford IJ. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br J Cancer 1996; 74 (S27).
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
5. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene-transcription by hypoxiainducible factor-1. Mol Cell Biol 1996; 16: 4604-4613.
6. Clauss M, Gerlach M, Gerlach H, et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-1545.
7. Waltenberger J, Lange J, Weich HA, Breier G, Rockl W, Clauss M. Vascular endothelial growth factor and placenta growth factor stimulate monocyte activation and chemotaxis via the VEGF-receptor-1. Circulation 1996; 94: 3475-3476.
8. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angio-genesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56: 4625-4626.
9. Lewis CE, Leek R, Harris AL, McGee JO'D. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 1995; 57: 747-751.
10. Zhang L, Scott PAE, Turley H. et al. Validation of antivascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections - expression of VEGF in the human endometrium. J Pathol 1998; 185: 402-408.
11. Leek RD, Landers R, Fox SB, Ng F, Harris AL, Lewis CE. Association of tumor necrosis factor-alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 1998; 77: 2246-2251.
12. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999; 79: 991-995.
13. McCarty KS, Miller LS, Cox EB, Konrath J, McCarty KS. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985; 109: 716-721.
14. European Breast Cancer Co-operative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute. Eur J Cancer 1980; 16: 1513-1515.
15. Nicholson S, Sainsbury JR, Needham GK, Chambers P, Farndon JR, Harris AL. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer 1988; 42: 36-41.
16. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995; 177: 275-283.
17. Sjogren S, Inganas M, Norberg T, et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 1996; 88: 173-182.
18. Anan K, Morisaki T, Katano M, et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 1996; 119: 333-339.
19. Gnarra JR, Zhou SB, Merrill MJ, et al. Posttranscriptional regulation of vascular endothelial growth factor messenger RNA by the product of the VHL tumor-suppressor gene. Proc Natl Acad Sci U S A 1996; 93: 10589-10594.
20. Gasparini G, Toi M, Gion M, et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 1997; 89: 139-147.
21. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994; 85: 1045-1049.
22. Obermair A, Kucera E, Mayerhofer K, et al. Vascular endothelial growth factor (VEGF) in human breast cancer -correlation with disease-free survival. Int J Cancer 1997; 74: 455-458.
23. Relf M, Lejeune S, Scott PAE, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor-beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997; 57: 963-969.
24. O'Sullivan C, Lewis CE, Harris AL, McGee JO'D. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancer 1993; 342: 148-149.
25. Chiappetta C, Stancel GM, Hyder SM. Estradiol (E2) regulates vascular endothelial growth factor (VEGF) messenger RNA in the uterus. Faseb J 1996; 10: 4094-4095.
26. Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-969.
27. Takahashi Y, Bucana CD, Cleary KR, Ellis LM. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 1998; 79: 34-38.
28. Crew JP, Obrien T, Bradburn M, et al. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 1997; 57: 5281-5285.
29. Levy AP, Levy NS, Goldberg MA. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel Lindau protein. J Biol Chem 1996; 271: 25492-25497.
30. Harmey JH, Dimitriadis E, Kay E, Redmond HP, Bouchierhayes D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol 1998; 5: 271-278.
31. Scannell G, Waxman K, Kaml GJ, et al. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res 1993; 54: 281-285.
32. Pusztai L, Clover LM, Cooper K, Starkey PM. Lewis CE, McGee JO'D. Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer 1994; 70: 289-292.
33. Toi M, Yamamoto Y, Taniguchi T, Saji S, Hayashi K, Tominaga T. Regulation of endothelial growth factor expression in breast cancer. Gan To Kagaku Ryoho 1996; 1: 75-79.
34. Lee AHS, Dublin EA, Borrow LG, Poulsom R. Invasive lobular and invasive ductal carcinoma of Othe breast show distinct patterns of vascular endothelial growth factor, expression and angiogenesis. J Pathol 1998; 185: 394-401.
35. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336-3343.
36. Patterson C, Perrella MA, Lee ME, Haber E. Tumor necrosis factor-alpha (TNF-alpha) decreases expression of the vascular endothelial growth factor (VEGF) receptor flk-1. Faseb J 1996; 10: 3140-3141.